Following the demerger and premium listing of Haleon in July 2022, GSK initially retained a 12.94% stake in Haleon. As a result of the disposals, GSK has sold 1.19 billion shares in Haleon for ...
The outgoing pharma chief exec (pictured) said it was 'absolutely critical' that the government 'incentivise' investment in ...
London-based consumer healthcare group Haleon Plc (NYSE:HLN) stock is trading lower on Thursday. Haleon, GSK Plc’s (NYSE:GSK) spun off, reported revenue of 11.23 billion pounds (US$14.19 billion) for ...
(Reuters) -Pfizer will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon, lowering its stake in the British consumer healthcare company to about 7.3% from 15%, its bookrunner JPMorgan ...
The FTSE 100 Index rose for four consecutive days and reached its all-time high of £9,578 as traders reacted to key earnings ...
Specialty medicines and other divisions show double-digit growth Expects annual revenue growth of 3% to 5%, core EPS 6% to 8% Outlook includes tariff impact, including EU deal July 30 (Reuters) - GSK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback